advertisement
Singh K 22
Showing records 1 to 22 |
Display all abstracts from Singh K118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorSamuelson TW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaSingh K
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudySun MT
Ophthalmology science 2024; 4: 100448
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaSingh A
Indian Journal of Ophthalmology 2024; 72: 391-396
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorDe Francesco T
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyCotton RM
Ophthalmology science 2024; 4: 100448
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaJain D
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyCharoenkijkajorn C
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorAhmed IIK
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaVerma V
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyGarcia-Sanchez J
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorGedde SJ
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyDalal R
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorParanjpe VR; Singh K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyXia X
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorBrubaker JW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyLin JH
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorGrover DS
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudySingh K; Goldberg JL
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorFellman RL
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyLiu WW
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorZhang AD; Barton K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103